Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-03

Clinical Trial Update: Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mini-dose methotrexate in combination with standard-dose steroids as initial treatment for acute graft-versus-host disease is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Graft Versus Host Disease | Phase 3 | Status: RECRUITING